Non-Melanoma Skin Cancer | How Is It Staged?

https://vimeo.com/1197896266 What factors could impact how a non-melanoma skin cancer is staged? Skin cancer expert Dr. Barbara Ma reviews key considerations that impact the cancer stage, including classification, lesion size…

When Is It Necessary to Repeat Key AML Tests?

https://vimeo.com/1195986327 Hematologist-oncologist Dr. Anand Patel explains why repeat testing is critical throughout AML care — from measuring the depth of remission with MRD testing to identifying new mutations if the…

Understanding MRD and Its Impact on AML Care

https://vimeo.com/1195986290 What is measurable residual disease (MRD), and why does it matter in AML care? Hematologist-oncologist Dr. Anand Patel explains how this advanced testing can detect tiny amounts of leukemia…

AML Treatment and Care Choices | The Role of Test Results

https://vimeo.com/1195986291 AML treatment options are expanding, giving patients more personalized approaches than ever before. AML specialist Dr. Anand Patel explains the differences between intensive chemotherapy and newer lower-intensity therapies, and…

Understanding AML Risk Categories and Why They Matter

https://vimeo.com/1195986292 What does it mean to have “favorable,” “intermediate,” or “adverse” risk AML, and how do those classifications affect treatment decisions? Hematologist-oncologist Dr. Anand Patel explains how in-depth test results…

Acute Myeloid Leukemia (AML): Which Tests Are Critical?

https://vimeo.com/1195986293 Understanding the purpose behind in-depth AML testing can help patients and care partners feel more informed and empowered. Hematologist-oncologist Dr. Anand Patel explains the key blood, bone marrow, molecular,…

Key Considerations When Choosing Bladder Cancer Therapy

https://vimeo.com/1194489703 What factors affect bladder cancer treatment options? Bladder cancer specialist Dr. Piyush Agarwal defines bladder cancer risk categories and lays out how these classifications can help guide treatment recommendations….

Share On:

Facebook
Twitter
LinkedIn